John Hopkins Medical Center

Baltimore, Maryland 21287

We've found

5 trials

at this facility

Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Baltimore, MD

Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Baltimore, MD

A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Baltimore, MD

AASUR in High Risk Prostate Cancer

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Baltimore, MD

Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Baltimore, MD

Use our guide to learn which trials are right for you!